Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Second-line Irinotecan and Capecitabine Versus Irinotecan for Gemcitabine and Cisplatin Refractory Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119)
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Treatment for Advanced Rectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study
- Status
- TERMINATED
- Phase
- PHASE1
Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- TERMINATED
- Phase
- PHASE2
A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase Ib, Open-label, Multicenter Study of the Safety and PK of the Combination of rhuMAb2c4 (Omnitarg), a Recombinant Humanized Antibody to HER2, and Capecitabine (Xeloda) in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)
- Status
- COMPLETED
- Phase
- PHASE3
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1